Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

medicalnewstoday.com

1 of 0

Resource Description:

FDA on Wednesday announced revisions to the labels of certain epilepsy, bipolar disorder and nerve pain medications to strengthen warnings about po

« Back to the FDA Warnings on Epilepsy Medicine WisdomCard

Related Health Centers:

Advertisement